p53 Nuclear overexpression: An independent predictor of survival in lymph node-positive colorectal cancer patients

Journal of Clinical Oncology

Volumn 12, Issue 10, 1994, Pages 2043-2050

  Zeng, Zhao Shi ^b   Sarkis, Alvaro S ^b   Zhang, Zuo Feng ^b   Klimstra, David S ^b   Charytonowicz, Elizabeth ^b   Guillem, Jose G ^b   Cordon Cardo, Carlos ^b   Cohen, Alfred M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; BIOTIN; CARCINOEMBRYONIC ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PAB 1801; PEROXIDASE; PROTEIN P53; SAPONIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0028171960     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1994.12.10.2043     Document Type: Article

References (44)

1. Moertel CG, Fleming TR, MacDonald JS, et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358, 1990
2. Krook JE, Moertel CG, Gunderson LL, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma, N Engl J Med 324:709-715, 1991
3. Cohen AM, Tremiterra S, Candela F, et al: Prognosis of node-positive colon cancer. Cancer 67:1859-1861, 1991
4. Wanebo JH, Rao B, Pinsky CM, et al: Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 299:448-451, 1978
5. Chapuis PH, Dent OF, Fisher R, et al: A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 72:698-702, 1985
6. Harris AL: Mutant p53 - The commonest genetic abnormality in human cancer? J Pathol 162:5-6, 1990
7. Pignatelli M, Stamp GW, Kafiri G, et al: Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer 50:683-688, 1992
8. Purdie CA, O'Grady J, Pins J, et al: p53 expression in colorectal tumors. Am J Pathol 138:807-813, 1991
9. Allred DC, Clark GM, Elledge R, et al: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85:200-206, 1993
10. Horio Y, Takahashi T, Kuroishi T, et al: Prognostic significance of p53 mutations and 3p detection in primary resected nonsmall cell lung cancer. Cancer Res 53:1-4, 1993
11. Rodriguez NR, Rowan A, Smith ME, et al: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555-7559, 1990
12. Lane DP, Crawford LV: T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261-263, 1979
13. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351:453-456, 1991
14. Lane DP, Benchimol S: p53: Oncogene or anti-oncogene? Genes Dev 4:1-8, 1990
15. Callahan R: p53 mutations, another breast cancer prognostic factor. J Natl Cancer Inst 84:826-827, 1992
16. Thor AD, Moore DH II, Edgerton SM, et al: Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers. J Natl Cancer Inst 84:845-855, 1992
17. Isola J, Visakorpi T, Holli K, et al: Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84:1109-1114, 1992
18. Quinlan DC, Davidson AG, Summers CL, et al: Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 52:4828-4831, 1992
19. Sarkis AS, Dalbagni G, Cordon-Cardo C, et al: Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression. J Natl Cancer Inst 85:53-59, 1993
20. Remvikos Y, Tominaga O, Hammel P, et al: Increased p53 protein content of colorectal tumors correlates with poor survival. Br J Cancer 66:758-764, 1992
21. Scott N, Sagar P, Stewart J, et al: p53 in colorectal cancer: Clinicopathological correlation and prognostic significance. Br J Cancer 63:317-319, 1991
22. Starzynska T, Bromley M, Ghosh A, et al: Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 66:558-562, 1992
23. O'Connell MJ, Schaid DJ, Ganju V, et al: Current status of adjuvant chemotherapy for colorectal cancer: Can molecular markers play a role in predicting prognosis? Cancer 70:1732-1739, 1992
24. Yamaguchi A, Kurosaka Y, Fushida S, et al: Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 70:2778-2784, 1992
25. Sun XF, Carstensen JM, Zhang H, et al: Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340:1369-1373, 1992
26. Bosari S, Viale G, Bossi P, et al: Cytoplasmic accumulation of p53 protein: An independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 86:681-687, 1994
27. Zeng ZS, Cohen AM, Urmacher C: Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis Colon Rectum 36:1063-1068, 1993
28. Banks L, Matlashewski G, Crawford L: Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 159:529-534, 1986
29. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Statist Assoc 53:457-481, 1958
30. Cox DR: Partial likelihood. Biometrika 62:269-279, 1975
31. Lothe RA, Fossli T, Danielssen HE, et al: Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors, J Natl Cancer Inst 84:1100-1108, 1992
32. Finlay CA, Hinds PW, Tan TH, et al: Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 8:531-539, 1988
33. Kerns BJ, Jordan PA, Moore MB, et al: p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry. J Histochem Cytochem 40:1047-1051, 1992
34. Wynford-Thomas D: p53 in tumor pathology: Can we trust immunocytochemistry? J Pathol 166:329-330, 1992
35. Scarpa A, Capelli P, Mukai K, et al: Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 142:1534-1543, 1993
36. Cesarman E, Inghirami G, Chadhurn A, et al: High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am J Pathol 143:845-856, 1993
37. Bartek J, Iggo R, Gannon J, et al: Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5:893-899, 1990
38. Vahakangas KH, Samet JM, Metcalf RA, et al: Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 339:576-580, 1992
39. Marks JR, Davidoff AM, Kerns BJ, et al: Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51:2979-2984, 1991
40. Navone NM, Troncoso P, Pisters LL, et al: p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85:1657-1669, 1993
41. Cordon-Cardo C, Dalbagni G, Saez GT, et al: p53 mutations in human bladder cancer: Genotypic versus phenotypic patters. Int J Cancer 56:347-353, 1994
42. Hollstein M, Sidransky D, Vogelstein B, et al: p53 mutation in human cancer. Science 253:49-53, 1991
43. Cunningham J, Lust JA, Schaid DJ, et al: Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 52:1974-1980, 1992
44. Kawasaki Y, Monden T, Morimoto H, et al: Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma. Am J Clin Pathol 97:244-249, 1992